MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2014-08-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10549-014-3069-5PMID 25086633
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Banana Ovate family protein MaOFP1 and MADS-box protein MuMADS1 antagonistically regulated banana fruit ripening

  2015cited by this paper
• MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis.

  2013cited by this paper
• Reduced Expression of miR-200 Family Members Contributes to Antiestrogen Resistance in LY2 Human Breast Cancer Cells

  2013cited by this paper
• LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker

  2012cited by this paper
• MicroRNA-200 Family Modulation in Distinct Breast Cancer Phenotypes

  2012cited by this paper
• The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer

  2012cited by this paper
• MicroRNA-9 as Potential Biomarker for Breast Cancer Local Recurrence and Tumor Estrogen Receptor Status

  2012cited by this paper
• MicroRNAs and breast cancer malignancy: An overview of miRNA-regulated cancer processes leading to metastasis

  2012cited by this paper
• Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes

  2012cited by this paper
• The Oncogenic Role of miR-155 in Breast Cancer

  2012cited by this paper
• Clinical significance of MicoRNA‐155 expression in human breast cancer

  2012cited by this paper
• Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155

  2011cited by this paper
• Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

  2011cited by this paper
• Heterogeneity for Stem Cell–Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer

  2010cited by this paper
• miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis

  2010influential reference
• Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression

  2010cited by this paper
• microRNAs and EMT in Mammary Cells and Breast Cancer

  2010cited by this paper
• The basics of epithelial-mesenchymal transition.

  2009cited by this paper
• Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

  2009cited by this paper
• A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis.

  2009cited by this paper
• Epithelial-mesenchymal transitions in development and disease.

  2009cited by this paper
• Endogenous human microRNAs that suppress breast cancer metastasis

  2008cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.

  2008cited by this paper
• The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis

  2008cited by this paper
• MicroRNA-155 Is Regulated by the Transforming Growth Factor β/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA

  2008cited by this paper
• The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

  2008cited by this paper
• Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype.

  2008cited by this paper
• Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin.

  2007cited by this paper
• Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

  2007cited by this paper
• MicroRNA signatures in human cancers

  2006cited by this paper
• A microRNA expression signature of human solid tumors defines cancer gene targets

  2006cited by this paper
• Oncomirs — microRNAs with a role in cancer

  2006cited by this paper
• MicroRNA gene expression deregulation in human breast cancer.

  2005cited by this paper
• Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

  2005cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper

• A study of kinetics of circulating miRNA-155 in patients of de-novo non-metastatic breast cancer with neoadjuvant chemotherapy and surgery

  2026cites this paper
• A circulating MicroRNA signature for the diagnosis of pulmonary arterial hypertension and functional characterization of candidate miR-3168.

  2026cites this paper
• Non-coding RNAs, a double-edged sword in breast cancer prognosis

  2025cites this paper
• The role of microRNAs in breast cancer: Diagnostic and therapeutic implications.

  2025cites this paper
• Micro-RNAs targeting the estrogen receptor alpha involved in endocrine therapy resistance in breast cancer.

  2025cites this paper
• Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic Strategies

  2024cites this paper
• miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine

  2024cites this paper
• EV-miRNA-Mediated Intercellular Communication in the Breast Tumor Microenvironment

  2023cites this paper
• Deregulated MicroRNAs involved in P53 Signaling Pathway in Breast Cancer with Focus on Triple-negative Breast Cancer.

  2023cites this paper
• Detailed role of microRNA‐mediated regulation of PI3K/AKT axis in human tumors

  2023cites this paper
• A positive TGF‐β/miR‐9 regulatory loop promotes the expansion and activity of tumour‐initiating cells in breast cancer

  2023cites this paper
• Extracellular Vesicles in Breast Cancer: From Biology and Function to Clinical Diagnosis and Therapeutic Management

  2023cites this paper
• miR-137 Regulates Proliferation, Migration, Invasion and EMT of Nasopharyngeal Carcinoma Cells by Targeting TWIST1

  2023cites this paper
• The Therapeutic Potential of a Strategy to Prevent Acute Myeloid Leukemia Stem Cell Reprogramming in Older Patients

  2023cites this paper
• Cancer Stem Cell Relationship with Pro-Tumoral Inflammatory Microenvironment

  2023cites this paper
• The role of microRNA-4723-5p regulated by c-myc in triple-negative breast cancer

  2022cites this paper
• Review article epithelial to mesenchymal transition‑associated microRNAs in breast cancer

  2022cites this paper
• The metabolic addiction of cancer stem cells

  2022cites this paper
• PA Imaging: A promising tool for targeted therapeutic implications in Cancer

  2022cites this paper
• Evaluation of Serum MicroRNAs (miR-9-5p, miR-17-5p, and miR-148a-3p) as Potential Biomarkers of Breast Cancer

  2022cites this paper
• A comprehensive review on oncogenic miRNAs in breast cancer

  2021cites this paper
• Tiny miRNAs Play a Big Role in the Treatment of Breast Cancer Metastasis

  2021cites this paper
• Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysis

  2021cites this paper
• MiRNAs in Canine and Human Osteosarcoma: A Highlight Review on Comparative Biomolecular Aspects

  2021cites this paper
• A comprehensive review on oncogenic miRNAs in breast cancer

  2021cites this paper
• Anesthetics may modulate cancer surgical outcome: a possible role of miRNAs regulation

  2021cites this paper
• Topic Evolution Analysis for Omics Data Integration in Cancers

  2021influential citation
• The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer

  2021cites this paper
• The Challenging Riddle about the Janus-Type Role of Hsp60 and Related Extracellular Vesicles and miRNAs in Carcinogenesis and the Promises of Its Solution

  2021cites this paper
• Yorkie drives Ras-induced tumor progression by microRNA-mediated inhibition of cellular senescence

  2021cites this paper
• Evaluation of miRNAs 9 and 342 expressions in sera as diagnostic and prognostic biomarkers for breast cancer

  2021cites this paper
• Extracellular vesicle-mediated transport: Reprogramming a tumor microenvironment conducive with breast cancer progression and metastasis

  2021cites this paper
• Role of Par-4 in EMT

  2021cites this paper
• Intercalating the Role of MicroRNAs in Cancer: As Enemy or Protector

  2020cites this paper
• Regulation of breast cancer metastasis signaling by miRNAs

  2020cites this paper
• Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration

  2020cites this paper
• Vitamin D and non-coding RNAs: new insights into the regulation of breast cancer.

  2020cites this paper
• Prognostic and Clinicopathological Significance of MiR-155 in Breast Cancer: A Systematic Review

  2020influential citation
• Non-coding RNAs: the new central dogma of cancer biology

  2020influential citation
• Candidate circulating microRNAs as potential diagnostic and predictive biomarkers for the monitoring of locally advanced breast cancer patients

  2020cites this paper
• MicroRNA-548m Suppresses Cell Migration and Invasion by Targeting Aryl Hydrocarbon Receptor in Breast Cancer Cells

  2020cites this paper
• miR-9-5p as a Regulator of the Androgen Receptor Pathway in Breast Cancer Cell Lines

  2020cites this paper
• Modulatory Role of microRNAs in Triple Negative Breast Cancer with Basal-Like Phenotype

  2020cites this paper
• LINC01116 promotes proliferation and migration of endometrial stromal cells by targeting FOXP1 via sponging miR‐9‐5p in endometriosis

  2020cites this paper
• TNF-α/miR-155 axis induces the transformation of osteosarcoma cancer stem cells independent of TP53INP1.

  2020cites this paper
• EMT Factors and Metabolic Pathways in Cancer

  2020cites this paper
• MicroRNAs, a Promising Target for Breast Cancer Stem Cells

  2019cites this paper
• Regulation of Ferroptosis by MicroRNAs

  2019cites this paper
• MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance, and Applications in Human Triple-Negative Breast Cancer

  2019cites this paper
• Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women.

  2019cites this paper
• Cancer stem‐like cells with hybrid epithelial/mesenchymal phenotype leading the collective invasion

  2019cites this paper
• Retracted: circSMAD2 governs migration and epithelial–mesenchymal transition by inhibiting microRNA‐9

  2019cites this paper
• Molecular characterization of lung cancer: A two‐miRNA prognostic signature based on cancer stem‐like cells related genes

  2019cites this paper
• Chemotherapy-induced extracellular vesicle miRNAs promote breast cancer stemness by targeting ONECUT2.

  2019cites this paper
• MicroRNA-9 and breast cancer.

  2019cites this paper
• Nanotechnology, in silico and endocrine-based strategy for delivering paclitaxel and miRNA: Prospects for the therapeutic management of breast cancer.

  2019cites this paper
• Exploring specific prognostic biomarkers in triple-negative breast cancer

  2019cites this paper
• LncRNA NEAT1 enhances the resistance of anaplastic thyroid carcinoma cells to cisplatin by sponging miR-9-5p and regulating SPAG9 expression

  2019cites this paper
• MiR-9 promotes synovial sarcoma cell migration and invasion by directly targeting CDH1.

  2019cites this paper
• MicroRNA-9 inhibits gastric cancer cell proliferation and migration by targeting neuropilin-1

  2019cites this paper
• Non-coding RNAs in endometriosis: a narrative review

  2018cites this paper
• Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer

  2018cites this paper
• MiR-130a-3p inhibits migration and invasion by regulating RAB5B in human breast cancer stem cell-like cells.

  2018cites this paper
• The mechanisms involved in miR-9 regulated apoptosis in cervical cancer by targeting FOXO3.

  2018cites this paper
• microRNA-9 functions as a tumor suppressor in colorectal cancer by targeting CXCR4.

  2018cites this paper
• Aberrant miRNA promoter methylation and EMT‐involving miRNAs in breast cancer metastasis: Diagnosis and therapeutic implications

  2018cites this paper
• Anti-miRNA oligonucleotides: A comprehensive guide for design

  2018cites this paper
• microRNA as a systemic intervention in the specific breast cancer subtypes with C‐MYC impacts; introducing subtype‐based appraisal tool

  2018cites this paper
• miRNA-135b Contributes to Triple Negative Breast Cancer Molecular Heterogeneity: Different Expression Profile in Basal-like Versus non-Basal-like Phenotypes

  2018cites this paper
• MiR-431 inhibits colorectal cancer cell invasion via repressing CUL4B.

  2018cites this paper
• Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer.

  2018cites this paper
• Emerging roles of microRNAs in cancer.

  2018cites this paper
• Suppressive and Hypermethylated MicroRNAs in the Pathogenesis of Breast Cancer

  2018cites this paper
• Lamins in Lung Cancer: Biomarkers and Key Factors for Disease Progression through miR-9 Regulation?

  2018cites this paper
• miR-185-5p inhibits F-actin polymerization and reverses epithelial mesenchymal transition of human breast cancer cells by modulating RAGE

  2018cites this paper
• Increased Cellular Levels of MicroRNA-9 and MicroRNA-221 Correlate with Cancer Stemness and Predict Poor Outcome in Human Breast Cancer

  2018cites this paper
• miR-9-5p in Nephrectomy Specimens is a Potential Predictor of Primary Resistance to First-Line Treatment with Tyrosine Kinase Inhibitors in Patients with Metastatic Renal Cell Carcinoma

  2018cites this paper
• microRNA-9 selectively targets LMX1A to promote gastric cancer cell progression.

  2018cites this paper
• COX-2 induces oncogenic micro RNA miR655 in human breast cancer

  2018cites this paper
• Lamines et cancer broncho-pulmonaire : biomarqueurs et facteurs clés dans le processus métastatique

  2018cites this paper
• Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors

  2018cites this paper
• MicroRNAs regulate the epithelial–mesenchymal transition and influence breast cancer invasion and metastasis

  2017cites this paper
• Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer

  2017cites this paper
• Bioinformatics identification of dysregulated microRNAs in triple negative breast cancer based on microRNA expression profiling

  2017cites this paper
• MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1

  2017cites this paper
• Role of exosome microRNA in breast cancer

  2017cites this paper
• Loss of N-Acetylgalactosaminyltransferase-4 Orchestrates Oncogenic MicroRNA-9 in Hepatocellular Carcinoma*

  2017cites this paper
• MicroRNA-222 Expression as a Predictive Marker for Tumor Progression in Hormone Receptor-Positive Breast Cancer

  2017cites this paper
• The role of hypoxia on the acquisition of epithelial-mesenchymal transition and cancer stemness: a possible link to epigenetic regulation

  2017cites this paper
• Prognostic value of microRNA-9 and microRNA-155 expression in triple-negative breast cancer.

  2017cites this paper
• Head and Neck Cancer: Epidemiology and Role of MicroRNAs

  2017cites this paper
• Análisis de los perfiles de expresión de microRNAs en cáncer de mama y de la implicación de la familia miR-200 en metástasis

  2017influential citation
• Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance

  2017cites this paper
• MiR-9 Promotes Apoptosis Via Suppressing SMC1A Expression in GBM Cell Lines

  2017cites this paper
• Analysis of cytotoxic T lymphocytes response activated dendritic cells vaccination using breast cancer stem-like cells

  2016cites this paper
• Prognostic value of microRNA-9 in cancers: a systematic review and meta-analysis

  2016cites this paper
• MiR-99a suppress proliferation, migration and invasion through regulating insulin-like growth factor 1 receptor in breast cancer.

  2016cites this paper
• Prognostic Value of microRNA-9 in Various Cancers: a Meta-analysis

  2016cites this paper
• ADAMTS6 suppresses tumor progression via the ERK signaling pathway and serves as a prognostic marker in human breast cancer

  2016cites this paper
• Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts

  2016cites this paper